Production of 225Ac and 223Ra by irradiation of Th with accelerated protons

被引：72

作者：

Zhuikov B.L. ^{[1
]}

Kalmykov S.N. ^{[2
]}

Ermolaev S.V. ^{[1
]}

Aliev R.A. ^{[2
]}

Kokhanyuk V.M. ^{[1
]}

Matushko V.L. ^{[1
]}

Tananaev I.G. ^{[3
]}

Myasoedov B.F. ^{[3
]}

机构：

[1] Institute for Nuclear Research, Russian Academy of Sciences, Moscow 117312

[2] Chemical Faculty, Lomonosov Moscow State University, Moscow

[3] Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences, Moscow

来源：

Radiochemistry | 2011年 / 53卷 / 1期

关键词：

actinium-225; chromatography; extraction; proton irradiation; radium-223; sublimation;

D O I：

10.1134/S1066362211010103

中图分类号：

学科分类号：

摘要：

The possibility of producing 225Ac and 223Ra by irradiation of natural 232Th with medium-energy protons was examined. Thorium foils were irradiated with 90-, 110-, and 135-MeV protons at the accelerator of the Institute for Nuclear Research, Russian Academy of Sciences, in Troitsk (Moscow oblast). The cumulative production cross sections for 225Ac were 6.7 ± 0.9, 9.8 ± 1.9, and 13.9 ± 1.5 mb, and for 227Th (223Ra precursor), 43 ± 5, 37 ± 6, and 35 ± 4 mb, respectively. Based on the experimental data and theoretical calculations, the possible yields of 225Ac and 223Ra in irradiation of thick thorium targets at various accelerators were determined. An efficient procedure was suggested for isolating the products from the irradiated targets: 225Ac, by liquid extraction and extraction chromatography, and 223Ra, by sublimation from a thorium-lanthanum melt followed by thermochromatographic separation in metallic titanium columns and extraction-chromatographic isolation of radium. The procedure allows production of large (units of curies) amounts of radiochemically pure 225Ac and 223Ra, which is promising for wide use of these radionuclides in nuclear medicine. © 2011 Pleiades Publishing, Ltd.

引用

页码：73 / 80

页数：7

共 27 条

[1]

Mulford D.A., Scheinberg D.A., Jurcic J.G., J. Nucl. Med., 46, (2005)

[2]

McDevitt M.R., Sgouros G., Finn R.D., Humm J.L., Jurcic J.G., Larson S.M., Scheinberg D.A., Radioimmunotherapy with alpha-emitting nuclides, European Journal of Nuclear Medicine, 25, 9, pp. 1341-1351, (1998)

[3]

Khalkin V.A., Tsupko-Sitnikov V.V., Zaitseva N.G., Radiokhimiya, 39, 6, pp. 481-490, (1997)

[4]

Pavlovich V.B., Dubinkin D.O., Kotovskii A.A., Et al., (2001)

[5]

Mirzadeh S., Garland M.A., (2009)

[6]

Chuvilin D.Yu., Il'In E.K., Markovskii D.V., Smetanin E.Ya., (2001)

[7]

Baranov V.Yu., Marchenkov N.S., Konvers. Mashinostr., 3, pp. 38-47, (2000)

[8]

Kuznetsov R.A., Butkalyuk P.S., Andreev O.I., Et al., Abstracts of Papers, Shestaya Rossiiskaya Konferentsiya Po Radiokhimii "radiokhimiya-2009" (Sixth Russian Conf. on Radiochemistry "radiochemistry-2009"), (2009)

[9]

Maslov O.D., Sabel'Nikov A.V., Dmitriev S.N., Radiokhimiya, 48, 2, pp. 176-179, (2006)

[10]

Apostolidis C., Janssens W., Koch L., Et al., (2001)

← 1 2 3 →